SENSEX NIFTY

Glaxo

Feb 23, 2017 at 17:54 | Source: Moneycontrol.com
Axis Direct recommended hold rating on Glaxosmithkline Consumer with a target price of Rs 5300 in its research report dated February 21, 2017.
Feb 20, 2017 at 13:25 | Source: Moneycontrol.com
Centrum is bearish on GlaxoSmithKline Pharma has recommended sell rating on the stock with a target price of Rs 1340 in its research report dated February 13, 2017.
Feb 20, 2017 at 08:26 | Source: CNBC-TV18
Idea Cellular | Axis Bank | Kotak Mahindra Bank | Hindustan Unilever | McNally Bharat | Havells | BPCL | GPT Infra | Mangalam Drugs and GSK Pharma are stocks, which are in the news today.
Feb 17, 2017 at 09:32 | Source: CNBC-TV18
Mahesh Nandurkar of CLSA expects FY18 Nifty earnings growth of 17 percent with small downside risk due to margin concern.
Feb 16, 2017 at 17:28 | Source: Moneycontrol.com
ICICI Direct is bullish on GSK Consumer has recommended buy rating on the stock with a target price of Rs 6102 in its research report dated February 14, 2017.
Feb 16, 2017 at 11:28 | Source: Moneycontrol.com
Edelweiss recommended hold rating on Glaxosmithkline with a target price of Rs 5773 in its research report dated February 13, 2017.
Feb 14, 2017 at 10:00 | Source: CNBC-TV18
CLSA has downgraded HPCL to sell from outperform, with increased target price at Rs 540 from Rs 480 and EPS for FY17 by 8 percent & by 1-2 percent for FY18-19. Core refining margin was disappointing for third straight quarter, the brokerage house says, adding it relaxed EV/EBITDA multiple to 7.5x from 7x earlier.
Feb 13, 2017 at 18:08 | Source: PTI
GlaxoSmithKline (GSK) ConsumerHealthcare Ltd today reported a 8.25 per cent decline in itsstandalone net profit at Rs 136.41 crore for the third quarterended on December 31, 2016, on the account of lower sales.
Feb 11, 2017 at 16:58 | Source: PTI
The company said mandatory price reductions experienced in the earlier quarters of the year had adversely impacted growth by 5 percent in the current quarter.
Feb 10, 2017 at 16:28 | Source: CNBC-TV18
Global drug major Novartis has invested, expanded its research & development (R&D) capabilities in India. The global leader in biosimilars through its subsidiary Sandoz is assessing Indian market dynamics to launch its portfolio.
Messages on Glaxo »

bestequitya
dvisors

New Member

1 Followers

GlaxoSmith Con  

Will you invest in GlaxoSmith Consumer for wealth creation in long term? Receive stock market updates for Free. http://t.in.com/b4cU

11.00 PM Feb 23rd

vijaykedia2
001

New Member

0 Follower

GlaxoSmith Con  

Will you invest in GlaxoSmith Consumer for wealth creation in long term? Receive stock market updates for Free. http://t.in.com/b4cU

10.58 PM Feb 22nd

Market Statistician

Platinum Member

20427 Followers

GlaxoSmith Con  

There has been a block deal of 16002 shares in GlaxoSmith Con at Rs 5185.00 per share, valued at Rs 8.30 crore on NSE today.

1.40 PM Feb 22nd

sptulsian19
60

New Member

3 Followers

GlaxoSmith Con  

Will you invest in GlaxoSmith Consumer for wealth creation in long term? Receive stock market updates for Free. http://t.in.com/b4cU

10.54 PM Feb 21st

simran311

New Member

153 Followers

GlaxoSmithKline  

Glaxo Smithkline is trading flat today but when to sell it? Google it----15 Proven Tips To Know Best And Right Time To Sell Stocks

10.33 AM Feb 21st

dollyvaluep
ick2

New Member

8 Followers

GlaxoSmith Con  

Will you invest in GlaxoSmith Consumer for wealth creation in long term? Receive stock market updates for Free. http://t.in.com/b4cU

10.39 PM Feb 20th

Forum Messenger

Platinum Member

376859 Followers

GlaxoSmithKline  

What is your view on GlaxoSmithKline Pharma?

1.25 PM Feb 20th

basantmahes
h1951

New Member

1 Followers

GlaxoSmith Con  

Will you invest in GlaxoSmith Consumer for wealth creation in long term? Receive stock market updates for Free. http://t.in.com/b4cU

7.40 PM Feb 18th

Market Statistician

Platinum Member

20427 Followers

GlaxoSmith Con  

There has been a block deal of 45000 shares in GlaxoSmith Con at Rs 5100.00 per share, valued at Rs 22.95 crore on BSE today.

1.50 PM Feb 17th

wealthcreat
ors2000

New Member

2 Followers

GlaxoSmith Con  

Will you invest in GlaxoSmith Consumer for wealth creation in long term? Receive stock market updates for Free. http://t.in.com/b4cU

11.06 PM Feb 16th

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.